Jump to content

User:Nicopolus/sandbox

From Wikipedia, the free encyclopedia
  • Comment: The first citation comes in the 'Publications' section – where is all the rest of this information coming from? DoubleGrazing (talk) 05:07, 13 August 2024 (UTC)
Nicopolus/sandbox
Retrato de Nahum Mendez Sanchez
Born (1956-04-27) April 27, 1956 (age 68)
Tlaxcala, México
EducationNational Autonomous University of Mexico
Occupation(s)Professor, Researcher, Physician

Nahum Méndez-Sánchez (born April 27, 1956) is a Mexican Physician and researcher known for his contributions to the field of Hepatology and Gastroenterology. He currently serves as a Professor at the National Autonomous University of Mexico (UNAM), where he has been involved in teaching and research for several decades.

Education

[edit]

Nahum Méndez-Sánchez completed his medical education at the National Autonomous University of Mexico, obtaining his Bachelor's degree in Medicine in 1984, followed by residency programs in Internal Medicine and Gastroenterology. He pursued further specialization with a Fellowship in Medicine (Hepatology) at Harvard University's Brigham & Women's Hospital from 1991 to 1993.

Professional Background

[edit]

Nahum Méndez-Sánchez has built a distinguished career by significant academic and administrative contributions in the field of medicine, particularly in gastroenterology, hepatology and internal medicine. His professional journey began with an internship at the National Autonomous University of Mexico from 1984 to 1985.

Following this, he assumed important roles such as Director of the Department of Biomedical Research at the Medica Sur Clinic and Foundation, a position he held for 22 years from 1996 to 2018. During this time, he played a crucial role in advancing biomedical research within the institution, contributing extensively to the field.

At the same time, Nahum Méndez-Sánchez was engaged in clinical research, notably as a Clinical Researcher in Gastroenterology and Hepatology at the Salvador Zubiran National Institute of Medical Sciences and Nutrition, as well as the Medica Sur Clinic and Foundation.

Since 1997, Nahum Méndez-Sánchez has also served as a Professor in Master's and Doctorate programs specializing in gastroenterology and hepatology at UNAM.

Nahum Méndez-Sánchez has served on the editorial boards of several prestigious scientific journals, including the American Journal of Gastroenterology, the Journal of Hepatology, and Gastroenterology. As the founder of the Annals of Hepatology, he has established a significant platform for disseminating cutting-edge research on liver diseases. His influence extends beyond publishing; he is a frequent chair and speaker at major international conferences. Additionally, Nahum Méndez-Sánchez is dedicated to mentoring young researchers and clinicians, playing a pivotal role in fostering the next generation of experts in liver disease.

As a emeritus researcher of the National System of Researchers (SNI), Nahum Méndez-Sánchez has participated in multiple national and international research projects. He has more than 17,000 citations and an h-index of 56. His extensive research contributions span various aspects of liver diseases, including metabolic dysfunction-associated steatotic liver disease (MASLD), alcohol-related liver disease (ALD), viral hepatitis, bilirubin metabolism, and acute-on-chronic liver failure (ACLF). Through his leadership and collaboration, he continues to drive innovation and excellence in hepatology research.

Research Focus

[edit]

Nahum Méndez-Sánchez's research primarily focuses on liver diseases, including:

His work has contributed significantly to understanding the pathophysiology and treatment of these conditions, with numerous publications in peer-reviewed journals and presentations at international conferences.

Honors and awards

[edit]

Nahum Méndez-Sánchez has received multiple awards and recognitions. Following is the list of his awards:

  • 2023 National Researcher Emeritus. National Council of Science and Technology. Mexico
  • 2022 2022 JCTH Outstanding Associate Editor
  • 2021 European Association for Study of Liver Disease (EASL) International Recognition Award
  • 2020 2020 Most Cited Article Award. Journal of Clinical Translational Hepatology
  • 2020 Best Paper Awards in 2018-2020—from Hepatoma Research Journal
  • 2017 "Honorary Editor" Award. Canadian Association for Study of the Liver
  • 2015 Editor Recognition Award. National Council of Science and Technology. Mexico
  • 2014 American College Governor for Mexico.
  • 2006 Best Book Award ("Clinical and Epidemiological Methods of Medical Research") National Academy of Medicine, Mexico
  • 1993 Fogarty International Scholarship Award Recipient. National Institutes of Health. United States of America
  • 1991 Fogarty International Scholarship Award Recipient. National Institutes of Health. United States of America
  • 1992 The Gabino Barreda Medal Award, for highest overall score in the Doctorate Medical Science Program. National Autonomous University of Mexico.
  • 1992 Honorable Mention for Academic Achievement in Doctorate Medical Sciences. National Autonomous University of Mexico.
  • 1991 Honorable Mention for Academic Achievement Master of Medical Sciences. National Autonomous University of Mexico
  • 1990 Internship Award. Juárez Hospital. Ministry of Health. Mexico

Publications

[edit]

Nahum Méndez-Sánchez has authored over 300 articles in national and international medical journals. Here is a list of his selected publications

  • Bariatric surgery for non-alcoholic steatohepatitis in obese patients[1]
  • Current concepts in the pathogenesis of nonalcoholic fatty liver disease[2]
  • Metabolic syndrome as a risk factor for gallstone disease[3]
  • Effect of ezetimibe on the prevention and dissolution of cholesterol gallstones[4]
  • Narrative review of hepatocellular carcinoma: from molecular bases to therapeutic approach[5]
  • Etiology of liver cirrhosis in Mexico[6]
  • Trends in liver disease prevalence in Mexico from 2005 to 2050 through mortality data[7]
  • Strong association between gallstones and cardiovascular disease[8]
  • Eosinophilic gastroenteritis[9]
  • Role of diet in cholesterol gallstone formation[10]
  • Prevalence of gallstone disease in Mexico[11]
  • Variation of the gene encoding the nuclear bile salt receptor FXR and gallstone susceptibility in mice and humans[12]
  • Fish oil (n-3) polyunsaturated fatty acids beneficially affect biliary cholesterol nucleation time in obese women losing weight[13]
  • Alcoholic liver disease[14]
  • Weight reduction and ursodeoxycholic acid in subjects with nonalcoholic fatty liver disease. A double-blind, placebo-controlled trial[15]
  • Prevalence of hepatitis C virus infection among hemodialysis patients at a tertiary-care hospital in Mexico City, Mexico[16]
  • Adiponectin as a protective factor in hepatic steatosis[17]
  • Lack of association between Helicobacter sp colonization and gallstone disease[18]
  • Plasma leptin and the cholesterol saturation of bile are correlated in obese women after weight loss[19]
  • Ursodeoxycholic acid and cholesterol induce enterohepatic cycling of bilirubin in rodents[20]

Public Engagement

[edit]

Beyond academia, Nahum Méndez-Sánchez actively engages in public outreach initiatives to raise awareness about liver diseases such as MAFLD[21]. He participates in public talks, educational programs, and media appearances, aiming to educate the general population about liver health and disease prevention.

References

[edit]
  1. ^ Chavez-Tapia, Norberto C.; Tellez-Avila, Felix I.; Barrientos-Gutierrez, Tonatiuh; Mendez-Sanchez, Nahum; Lizardi-Cervera, Javier; Uribe, Misael (2010-01-20). "Bariatric surgery for non-alcoholic steatohepatitis in obese patients". The Cochrane Database of Systematic Reviews. 2010 (1): CD007340. doi:10.1002/14651858.CD007340.pub2. ISSN 1469-493X. PMC 7208314. PMID 20091629.
  2. ^ Méndez-Sánchez, Nahum; Arrese, Marco; Zamora-Valdés, Daniel; Uribe, Misael (May 2007). "Current concepts in the pathogenesis of nonalcoholic fatty liver disease". Liver International: Official Journal of the International Association for the Study of the Liver. 27 (4): 423–433. doi:10.1111/j.1478-3231.2007.01483.x. ISSN 1478-3223. PMID 17403181. Retrieved 2024-08-11.
  3. ^ Méndez-Sánchez, Nahum; Chavez-Tapia, Norberto C.; Motola-Kuba, Daniel; Sanchez-Lara, Karla; Ponciano-Rodríguez, Guadalupe; Baptista, Héctor; Ramos, Martha H.; Uribe, Misael (2005-03-21). "Metabolic syndrome as a risk factor for gallstone disease". World Journal of Gastroenterology. 11 (11): 1653–1657. doi:10.3748/wjg.v11.i11.1653. ISSN 1007-9327. PMC 4305948. PMID 15786544.
  4. ^ Wang, Helen H.; Portincasa, Piero; Mendez-Sanchez, Nahum; Uribe, Misael; Wang, David Q.-H. (June 2008). "Effect of ezetimibe on the prevention and dissolution of cholesterol gallstones". Gastroenterology. 134 (7): 2101–2110. doi:10.1053/j.gastro.2008.03.011. ISSN 1528-0012. PMC 2741499. PMID 18442485.
  5. ^ Méndez-Sánchez, Nahum; Valencia-Rodríguez, Alejandro; Coronel-Castillo, Carlos E.; Qi, Xingshun (2021-03-30). "Narrative review of hepatocellular carcinoma: from molecular bases to therapeutic approach". Digestive Medicine Research. 4: 15. doi:10.21037/dmr-20-116. ISSN 2617-1627. Retrieved 2024-08-12.
  6. ^ Méndez-Sánchez, Nahum; Aguilar-Ramírez, Juan R.; Reyes, Angel; Dehesa, Margarita; Juórez, Alberto; Castñeda, Beatriz; Sánchez-Avila, Francisco; Poo, Jorge L.; Guevara González, Luis (2004). "Etiology of liver cirrhosis in Mexico". Annals of Hepatology. 3 (1): 30–33. doi:10.1016/S1665-2681(19)32122-2. ISSN 1665-2681. PMID 15118577. Retrieved 2024-08-12.
  7. ^ Méndez-Sánchez, Nahum; Villa, Antonio R.; Chávez-Tapia, Norberto C.; Ponciano-Rodriguez, Guadalupe; Almeda-Valdés, Paloma; González, Daniela; Uribe, Misael (2005). "Trends in liver disease prevalence in Mexico from 2005 to 2050 through mortality data". Annals of Hepatology. 4 (1): 52–55. doi:10.1016/S1665-2681(19)32086-1. ISSN 1665-2681. PMID 15798662. Retrieved 2024-08-12.
  8. ^ Méndez-Sánchez, Nahum; Bahena-Aponte, Jesús; Chávez-Tapia, Norberto C.; Motola-Kuba, Daniel; Sánchez-Lara, Karla; Ponciano-Radríguez, Guadalupe; Ramos, Martha H.; Uribe, Misael (April 2005). "Strong association between gallstones and cardiovascular disease". The American Journal of Gastroenterology. 100 (4): 827–830. doi:10.1111/j.1572-0241.2005.41214.x. ISSN 0002-9270. PMID 15784027. Retrieved 2024-08-12.
  9. ^ Méndez-Sánchez, Nahum; Chávez-Tapia, Norberto C.; Vazquez-Elizondo, Genaro; Uribe, Misael (November 2007). "Eosinophilic gastroenteritis: a review". Digestive Diseases and Sciences. 52 (11): 2904–2911. doi:10.1007/s10620-005-9011-2. ISSN 0163-2116. PMID 17429740. Retrieved 2024-08-12.
  10. ^ Méndez-Sánchez, Nahum; Zamora-Valdés, Daniel; Chávez-Tapia, Norberto C.; Uribe, Misael (February 2007). "Role of diet in cholesterol gallstone formation". Clinica Chimica Acta; International Journal of Clinical Chemistry. 376 (1–2): 1–8. doi:10.1016/j.cca.2006.08.036. ISSN 0009-8981. PMID 17055469. Retrieved 2024-08-12.
  11. ^ Méndez-Sánchez, N.; Jessurun, J.; Ponciano-Rodríguez, G.; Alonso-de-Ruiz, P.; Uribe, M.; Hernández-Avila, M. (April 1993). "Prevalence of gallstone disease in Mexico. A necropsy study". Digestive Diseases and Sciences. 38 (4): 680–683. doi:10.1007/BF01316800. ISSN 0163-2116. PMID 8462367. Retrieved 2024-08-12.
  12. ^ Kovacs, Peter; Kress, Rahel; Rocha, Jacqueline; Kurtz, Ulrike; Miquel, Juan Francisco; Nervi, Flavio; Méndez-Sánchez, Nahum; Uribe, Misael; Bock, Hans H. (January 2008). "Variation of the gene encoding the nuclear bile salt receptor FXR and gallstone susceptibility in mice and humans". Journal of Hepatology. 48 (1): 116–124. doi:10.1016/j.jhep.2007.07.027. ISSN 0168-8278. PMID 17931734. Retrieved 2024-08-12.
  13. ^ Méndez-Sánchez, N.; González, V.; Aguayo, P.; Sánchez, J. M.; Tanimoto, M. A.; Elizondo, J.; Uribe, M. (September 2001). "Fish oil (n-3) polyunsaturated fatty acids beneficially affect biliary cholesterol nucleation time in obese women losing weight". The Journal of Nutrition. 131 (9): 2300–2303. doi:10.1093/jn/131.9.2300. ISSN 0022-3166. PMID 11533270. Retrieved 2024-08-12.
  14. ^ Méndez-Sánchez, Nahum; Almeda-Valdés, Paloma; Uribe, Misael (2005). "Alcoholic liver disease. An update". Annals of Hepatology. 4 (1): 32–42. doi:10.1016/S1665-2681(19)32083-6. ISSN 1665-2681. PMID 15798659. Retrieved 2024-08-12.
  15. ^ Méndez-Sánchez, Nahum; González, Verónica; Chávez-Tapia, Norberto; Ramos, Martha H.; Uribe, Misael (2004). "Weight reduction and ursodeoxycholic acid in subjects with nonalcoholic fatty liver disease. A double-blind, placebo-controlled trial". Annals of Hepatology. 3 (3): 108–112. doi:10.1016/S1665-2681(19)32103-9. ISSN 1665-2681. PMID 15505596. Retrieved 2024-08-12.
  16. ^ Méndez-Sánchez, Nahum; Motola-Kuba, Daniel; Chavez-Tapia, Norberto C.; Bahena, Jesús; Correa-Rotter, Ricardo; Uribe, Misael (September 2004). "Prevalence of hepatitis C virus infection among hemodialysis patients at a tertiary-care hospital in Mexico City, Mexico". Journal of Clinical Microbiology. 42 (9): 4321–4322. doi:10.1128/JCM.42.9.4321-4322.2004. ISSN 0095-1137. PMC 516306. PMID 15365034.
  17. ^ Mendez-Sanchez, Nahum; Chavez-Tapia, Norberto-C.; Villa, Antonio-R.; Sanchez-Lara, Karla; Zamora-Valdes, Daniel; Ramos, Martha-H.; Uribe, Misael (2005-03-28). "Adiponectin as a protective factor in hepatic steatosis". World Journal of Gastroenterology. 11 (12): 1737–1741. doi:10.3748/wjg.v11.i12.1737. ISSN 1007-9327. PMC 4305865. PMID 15793855.
  18. ^ Méndez-Sánchez, N.; Pichardo, R.; González, J.; Sánchez, H.; Moreno, M.; Barquera, F.; Estevez, H. O.; Uribe, M. (February 2001). "Lack of association between Helicobacter sp colonization and gallstone disease". Journal of Clinical Gastroenterology. 32 (2): 138–141. doi:10.1097/00004836-200102000-00009. ISSN 0192-0790. PMID 11205649. Retrieved 2024-08-12.
  19. ^ Méndez-Sánchez, Nahum; González, Verónica; King-Martínez, Ana Cristina; Sánchez, Hiramm; Uribe, Misael (August 2002). "Plasma leptin and the cholesterol saturation of bile are correlated in obese women after weight loss". The Journal of Nutrition. 132 (8): 2195–2198. doi:10.1093/jn/132.8.2195. ISSN 0022-3166. PMID 12163661. Retrieved 2024-08-12.
  20. ^ Méndez-Sánchez, N.; Brink, M. A.; Paigen, B.; Carey, M. C. (September 1998). "Ursodeoxycholic acid and cholesterol induce enterohepatic cycling of bilirubin in rodents". Gastroenterology. 115 (3): 722–732. doi:10.1016/s0016-5085(98)70152-0. ISSN 0016-5085. PMID 9721170. Retrieved 2024-08-12.
  21. ^ Nahum Méndez-Sánchez (2023-01-21). "Screening for MAFLD: who, when and how?". Therapeutic Advances in Endocrinology and Metabolism. 14. doi:10.1177/20420188221145650. PMC 9869195. PMID 36699945.{{cite journal}}: CS1 maint: date and year (link)
Retrieved from "https://en.wikipedia.org/w/index.php?title=User:Nicopolus/sandbox&oldid=1240313504"